Literature DB >> 28688704

Long-Term Survival of Patients With Left Bundle Branch Block Who Are Hypo-Responders to Cardiac Resynchronization Therapy.

Himabindu Vidula1, Valentina Kutyifa2, Scott McNitt2, Ilan Goldenberg3, Scott D Solomon4, Arthur J Moss2, Wojciech Zareba2.   

Abstract

Guidelines support cardiac resynchronization therapy with a defibrillator (CRT-D) in mild heart failure (HF) patients with left bundle branch block (LBBB). However, not all patients demonstrate echocardiographic or clinical response to CRT-D. We aimed to evaluate the long-term outcomes of echocardiographic hypo-responders and clinical hypo-responders to CRT-D with LBBB in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy. Five-hundred thirty-four patients with LBBB in the CRT-D arm were followed for 5.6 years (median). Clinical hypo-response was defined as HF event in the first year after CRT-D implantation. Echocardiographic hypo-response was defined as ≤35% reduction (median) in left ventricular end-systolic volume 1 year after CRT-D implantation without evidence of clinical hypo-response. Echocardiographic and clinical response was observed in 257 patients (48%). Two-hundred fifty patients (47%) were echocardiographic hypo-responders and 27 patients (5%) were clinical hypo-responders. Echocardiographic hypo-responders had increased risk of all-cause mortality compared with echocardiographic + clinical responders (hazard ratio [HR] 2.85, 95% confidence interval [CI]: 1.37 to 5.94, p = 0.005). Clinical hypo-responders had increased risk of mortality compared with echocardiographic + clinical responders (HR 7.49, 95% CI: 2.88 to 19.48, p <0.0001) and compared with echocardiographic hypo-responders (HR 2.63, 95% CI: 1.17 to 5.92, p = 0.020). In conclusion, during long-term follow-up, patients with mild HF and LBBB who have echocardiographic hypo-response to CRT, with or without clinical signs of worsening HF, have increased risk of mortality. This study emphasizes the prognostic significance of echocardiographic assessment of left ventricular volume after CRT implantation in LBBB patients with mild HF.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28688704     DOI: 10.1016/j.amjcard.2017.06.001

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

Review 1.  Updates on Device-Based Therapies for Patients with Heart Failure.

Authors:  Jad Al Danaf; Javed Butler; Amin Yehya
Journal:  Curr Heart Fail Rep       Date:  2018-04

2.  Shortening of time-to-peak left ventricular pressure rise (Td) in cardiac resynchronization therapy.

Authors:  Hans Henrik Odland; Manuel Villegas-Martinez; Stian Ross; Torbjørn Holm; Richard Cornelussen; Espen W Remme; Erik Kongsgard
Journal:  ESC Heart Fail       Date:  2021-09-12

3.  Remote Hemodynamic-Guided Therapy of Patients With Recurrent Heart Failure Following Cardiac Resynchronization Therapy.

Authors:  Niraj Varma; Robert C Bourge; Lynne Warner Stevenson; Maria Rosa Costanzo; David Shavelle; Philip B Adamson; Greg Ginn; John Henderson; William T Abraham
Journal:  J Am Heart Assoc       Date:  2021-02-25       Impact factor: 5.501

4.  Value of intraventricular dyssynchrony assessment by gated-SPECT myocardial perfusion imaging in the management of heart failure patients undergoing cardiac resynchronization therapy (VISION-CRT).

Authors:  Amalia Peix; Ganesan Karthikeyan; Teresa Massardo; Mani Kalaivani; Chetan Patel; Luz M Pabon; Amelia Jiménez-Heffernan; Erick Alexanderson; Sadaf Butt; Alka Kumar; Victor Marin; Claudio T Mesquita; Olga Morozova; Diana Paez; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2019-01-25       Impact factor: 5.952

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.